From: External quality assessment scheme for sperm DNA fragmentation: a pilot study in China
Basic information | 2021 | 2022 |
---|---|---|
Number of participants | 10 | 28 |
Geographical distribution | ||
Provinces | 2 | 6 |
Cities | 5 | 13 |
Type of laboratories | ||
Andrology laboratory | 8/10 (80.0%) | 25/28 (89.3%) |
Clinical laboratory | 2/10 (20.0%) | 3/28 (10.7%) |
Hospital grade | ||
Tertiary hospital | 8/10 (80.0%) | 24/28 (85.6%) |
Secondary hospital | 1/10 (10.0%) | 2/28 (7.2%) |
Primary hospital | 1/10 (10.0%) | 2/28 (7.2%) |
Detection Method | ||
SCSA | 5/10 (50.0%) | 17/28 (60.7%) |
SCD | 5/10 (50.0%) | 11/28 (39.3%) |